Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas E Witzig

Showing results (181-190 of 387) with videos related to

Pageof 39
Sort By:
Blood|July 15, 2004
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeAnne J Novak, Deanna M Grote, Mary Stenson, et al.
Mayo Clinic Proceedings|July 13, 2004
Clinical course of patients with relapsed multiple myelomaShaji K Kumar, Terry M Therneau, Morie A Gertz, et al.
Haematologica|October 14, 2011
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaLuis F Porrata, Kay Ristow, Joseph P Colgan, et al.
Haematologica|April 24, 2024
Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemiaGordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, et al.
Blood|June 16, 2011
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphomaIvana N M Micallef, Matthew J Maurer, Gregory A Wiseman, et al.
British Journal of Haematology|April 7, 2009
Risk of non-Hodgkin lymphoma in association with germline variation in complement genesJames R Cerhan, Anne J Novak, Zachary S Fredericksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphomaThomas E Witzig, Susan M Geyer, Irene Ghobrial, et al.
Blood|July 28, 2019
Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphomaYucai Wang, Brian K Link, Thomas E Witzig, et al.
British Journal of Haematology|February 25, 2012
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
British Journal of Haematology|April 17, 2007
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomasDeepti Behl, Kay Ristow, Svetomir N Markovic, et al.
Pageof 39

Showing results (181-190 of 387) with videos related to

Sort By:
Pageof 39
Blood|July 15, 2004
Expression of BLyS and its receptors in B-cell non-Hodgkin lymphoma: correlation with disease activity and patient outcomeAnne J Novak, Deanna M Grote, Mary Stenson, et al.
Mayo Clinic Proceedings|July 13, 2004
Clinical course of patients with relapsed multiple myelomaShaji K Kumar, Terry M Therneau, Morie A Gertz, et al.
Haematologica|October 14, 2011
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in classical Hodgkin's lymphomaLuis F Porrata, Kay Ristow, Joseph P Colgan, et al.
Haematologica|April 24, 2024
Monocyte response to SARS-CoV-2 protein ORF8 is associated with severe COVID-19 infection in patients with chronic lymphocytic leukemiaGordon J Ruan, Xiaosheng Wu, Kimberly A Gwin, et al.
Blood|June 16, 2011
Epratuzumab with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated diffuse large B-cell lymphomaIvana N M Micallef, Matthew J Maurer, Gregory A Wiseman, et al.
British Journal of Haematology|April 7, 2009
Risk of non-Hodgkin lymphoma in association with germline variation in complement genesJames R Cerhan, Anne J Novak, Zachary S Fredericksen, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Phase II trial of single-agent temsirolimus (CCI-779) for relapsed mantle cell lymphomaThomas E Witzig, Susan M Geyer, Irene Ghobrial, et al.
Blood|July 28, 2019
Impact of concurrent indolent lymphoma on the clinical outcome of newly diagnosed diffuse large B-cell lymphomaYucai Wang, Brian K Link, Thomas E Witzig, et al.
British Journal of Haematology|February 25, 2012
Peripheral blood lymphocyte/monocyte ratio at diagnosis and survival in nodular lymphocyte-predominant Hodgkin lymphomaLuis F Porrata, Kay Ristow, Thomas M Habermann, et al.
British Journal of Haematology|April 17, 2007
Absolute lymphocyte count predicts therapeutic efficacy of rituximab therapy in follicular lymphomasDeepti Behl, Kay Ristow, Svetomir N Markovic, et al.
Pageof 39